McCann FitzGerald LLP advising Alkermes plc on its acquisition of Avadel Pharmaceuticals plc

We are delighted to be advising Alkermes plc on its acquisition of Avadel Pharmaceuticals plc, a commercial-stage biopharmaceutical company in a deal valued at up to $2.1 billion.

The McCann FitzGerald LLP team is led by Stephen FitzSimons, Jack Kelly and Gill Lohan (Corporate and M&A), Mark O’Connor and Stuart McCarron (Debt Finance) and Alan Heuston (Tax). The team includes Jack O’Reilly, Clarissa Mulcahy and Ben Arrowsmith (Corporate and M&A), Riona Connaughton (Debt Finance), Deirdre Barnicle, James Quirke and Cian O’Rourke (Tax), Laura Treacy, Stephen Ryan and Andrea Higgins (Antitrust and Competition) and Mary Brassil and Dara O’Toole (Employment).

Key Contacts